This Article is From Mar 26, 2023

Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market

The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.

Advertisement
India News

Drug firm Zydus Lifesciences is recalling over 55,000 bottles of generic medication in the US market due to failed impurities specifications.

As per the latest enforcement report by the US Food and Drug Administration (USFDA), Zydus Pharmaceuticals (USA) Inc is recalling 21,936 (30 count) and 33,096 (100 count) bottles of Colchicine tablets, which are used to treat gout.

The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.

USFDA said the company is recalling the product due to "failed impurities/ degradation specifications".

An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine, it added.

Advertisement

Zydus commenced the Class III recall on February 24 this year.

As per the USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".

Advertisement

The US market is the largest market for generic pharmaceutical products. The market was estimated to be around USD 115.2 billion in 2019.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Featured Video Of The Day

PM Modi Pays Tribute To Mahatma Gandhi In Guyana

Advertisement